Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women

Completed · Phase 3

Conditions studied: Nausea and Vomiting, Postoperative

In brief

This study is being conducted to see if adding GW679769 (casopitant) to ZOFRAN will significantly decrease the number of patients who experience nausea and vomiting after surgery.

Key facts

Study ID

NCT00326248

Run by

GlaxoSmithKline

People needed

482

Starts

2006-03-01

Expected to finish

2006-07-01

Last updated by the study team

2016-10-26

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• History of PONV and/or motion sickness.
• Have not smoked for the last 6 months.
• Having certain types of abdominal, breast or shoulder surgeries.

You may not qualify if…

• Pregnant or breastfeeding.
• Taking certain medications.
• Have certain pre-existing medical conditions.

Where it is running

• GSK Investigational Site — Sheffield, Alabama, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Boynton Beach, Florida, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Melbourne, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Naples, Florida, United States
• GSK Investigational Site — Pensacola, Florida, United States
• GSK Investigational Site — Anderson, Indiana, United States
• GSK Investigational Site — Grand Rapids, Michigan, United States
• GSK Investigational Site — Jackson, Mississippi, United States
• GSK Investigational Site — Omaha, Nebraska, United States
• GSK Investigational Site — New Brunswick, New Jersey, United States
• GSK Investigational Site — New Brunswick, New Jersey, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — The Bronx, New York, United States
• GSK Investigational Site — Altoona, Pennsylvania, United States
• GSK Investigational Site — Philadelphia, Pennsylvania, United States
• GSK Investigational Site — Pittsburgh, Pennsylvania, United States
• GSK Investigational Site — Pittsburgh, Pennsylvania, United States
• GSK Investigational Site — Houston, Texas, United States
• GSK Investigational Site — San Antonio, Texas, United States
• GSK Investigational Site — Montgomery, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.